These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1438 related items for PubMed ID: 11441936

  • 1. A systematic overview of chemotherapy effects in breast cancer.
    Bergh J, Jönsson PE, Glimelius B, Nygren P, SBU-group. Swedish Council of Technology Assessment in Health Care.
    Acta Oncol; 2001; 40(2-3):253-81. PubMed ID: 11441936
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 Sep 19; 352(9132):930-42. PubMed ID: 9752815
    [Abstract] [Full Text] [Related]

  • 4. WITHDRAWN: Multi-agent chemotherapy for early breast cancer.
    Clarke MJ.
    Cochrane Database Syst Rev; 2008 Oct 08; 2008(4):CD000487. PubMed ID: 18843612
    [Abstract] [Full Text] [Related]

  • 5. A systematic overview of chemotherapy effects in colorectal cancer.
    Ragnhammar P, Hafström L, Nygren P, Glimelius B, SBU-group. Swedish Council of Technology Assessment in Health Care.
    Acta Oncol; 2001 Oct 08; 40(2-3):282-308. PubMed ID: 11441937
    [Abstract] [Full Text] [Related]

  • 6. A systematic overview of chemotherapy effects in ovarian cancer.
    Högberg T, Glimelius B, Nygren P, SBU-group. Swedish Council of Technology Assessment in Health Care.
    Acta Oncol; 2001 Oct 08; 40(2-3):340-60. PubMed ID: 11441940
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, Cutter D, Darby S, McGale P, Taylor C, Wang YC, Bergh J, Di Leo A, Albain K, Swain S, Piccart M, Pritchard K.
    Lancet; 2012 Feb 04; 379(9814):432-44. PubMed ID: 22152853
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    CMAJ; 1998 Feb 10; 158 Suppl 3():S52-64. PubMed ID: 9484279
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.
    Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Electronic address: bc.overview@ctsu.ox.ac.uk, Early Breast Cancer Trialists’ Collaborative Group (EBCTCG).
    Lancet; 2023 Apr 15; 401(10384):1277-1292. PubMed ID: 37061269
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.